Massachusetts Selecta Biosciences' CEO to Retire at the End of 2018 Post author:Sam Post published:January 1, 2018 Post category:BioPharma Werner Cautreels, Ph.D., intends to retire effective December 31, 2018. Source: BioSpace You Might Also Like Novartis' Tasigna Wins FDA Nod for First and Only CML Therapy With Treatment-Free Remission Data … December 26, 2017 <b>Repare Therapeutics</b> Bursts From Stealth Mode With $68 Million and a Team Packed With Industry Alums June 21, 2017 Jazz Pharma Bets $175 Million on This Massachusetts Biotech's Antibody-Drug Program August 28, 2017
Novartis' Tasigna Wins FDA Nod for First and Only CML Therapy With Treatment-Free Remission Data … December 26, 2017
<b>Repare Therapeutics</b> Bursts From Stealth Mode With $68 Million and a Team Packed With Industry Alums June 21, 2017
